|
|
Volumn 9, Issue 7, 2010, Pages 501-503
|
|
Excitement grows for potential revolution in hepatitis C virus treatment
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BOCEPREVIR;
INTERFERON;
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;
NONSTRUCTURAL PROTEIN 5A INHIBITOR;
PEGINTERFERON;
PROTEINASE INHIBITOR;
RIBAVIRIN;
TELAPREVIR;
UNCLASSIFIED DRUG;
ANEMIA;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
DEPRESSION;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TOLERABILITY;
FLU LIKE SYNDROME;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
PUBLICATION;
SHORT COURSE THERAPY;
SHORT SURVEY;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
VIRUS REPLICATION;
ANTIVIRAL AGENTS;
CLINICAL TRIALS, PHASE I AS TOPIC;
CLINICAL TRIALS, PHASE III AS TOPIC;
DRUG RESISTANCE, VIRAL;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
OLIGOPEPTIDES;
PROLINE;
PROTEASE INHIBITORS;
|
|
EID: 77954233516
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3214 Document Type: Short Survey |
|
Times cited : (21)
|
|
References (0)
|
